Brigitte Thériault

Brigitte Thériault

Company: Fusion Pharmaceuticals

Job title: Sr. Director, Biology


Clinical Advances of 225Ac-targeted Antibody & Small Molecule-based Agents & Revealing Preclinical Insights from Immune Checkpoint Combination Approaches 11:45 am

Outlining why 225Ac is an attractive radioisotope for targeted therapy Exploring clinical strategy and updates on Fusion’s antibody and small molecule programs, including FPI-2265 (a phase 2/3 study) Revealing rational drug combinations for targeted alpha therapeuticsRead more

day: Day One LSC AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.